Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction

Author:

Hu Yingchun1,Chen Xiaoyu2,Mei Xiyuan1,Luo Zhen1,Wu Hongguang3,Zhang Hao1,Zeng Qingchun4,Ren Hao5,Xu Dingli4

Affiliation:

1. State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University , Guangzhou , 510515, Guangdong , China

2. Department of Nephrology, Rheumatism and Immunology, Chongqing Jiulongpo People’s Hospital , Chongqing , 400050 , China

3. Department of Arrhythmic, Cardiovascular Medical Center, Shenzhen Hospital of University of Hong Kong , Shenzhen , 518040, Guangdong , China

4. Department of Cardiology, Nanfang Hospital, Southern Medical University , Guangzhou , 510515, Guangdong , China

5. Department of Rheumatology, Nanfang Hospital, Southern Medical University , Guangzhou , 510515, Guangdong , China

Abstract

Abstract Post-myocardial infarction heart failure (HF) is a major public health concern. Previous studies have reported the critical role of immune response in HF pathogenesis. However, limited studies have reported predictive immune-associated biomarkers for HF. So we attempted to identify potential immune-related indicators for HF early diagnosis and therapy guidance. This study identified two potential immune-related hub genes (IRHGs), namely CXCR5 and FOS, using bioinformatic approaches. The expression levels of CXCR5 and FOS and their ability to predict long-term HF were analyzed. Functional enrichment analysis revealed that the hub genes were enriched in immune system processes, including the interleukin-17 and nuclear factor-kappa B signaling pathways, which are involved in the pathogenesis of HF. Quantitative real-time polymerase chain reaction revealed that the Fos mRNA levels, but not the Cxcr5 mRNA levels, were downregulated in the mice of the HF group. This study successfully identified two IRHGs that were significantly and differentially expressed in the HF group and could predict long-term HF, providing novel insights for future studies on HF and developing novel therapeutic targets for HF.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3